Abstract:Introduction: Allergic reactions are mediated by human IgE antibodies that bind to and cross-link allergen molecules. The sites on allergens that are recognized by IgE antibodies have been difficult to investigate because of the paucity of IgE antibodies in a human serum. Here, we report the production of unique human IgE monoclonal antibodies to major inhaled allergens and food allergens that can be produced at scale in perpetuity. Materials and methods: The IgE antibodies were derived from peripheral blood mononuclear cells of symptomatic allergic patients, mostly children aged 3-18 years, using hybridoma fusion technology. Total IgE and allergen-specific IgE was measured by ImmunoCAP. Their specificity was confirmed through ELISA and immunoblotting. Allergenic potency measurements were determined by ImmunoCAP inhibition. Biological activity was determined in vitro by comparing β-hexosaminidase release from a humanized rat basophilic cell line. Results: Human IgE monoclonal antibodies (n = 33) were derived from 17 allergic patients with symptoms of allergic rhinitis, asthma, atopic dermatitis, food allergy, eosinophilic esophagitis, or red meat allergy. The antibodies were specific for five inhaled allergens, nine food allergens, and alpha-gal and had high levels of IgE (53,450-1,702,500 kU/L) with ratios of specific IgE to total IgE ranging from <0.01 to 1.39. Sigmoidal allergen binding curves were obtained through ELISA, with low limits of detection (<1 kU/L). Allergen specificity was confirmed through immunoblotting. Pairs of IgE monoclonal antibodies to Ara h 6 were identified that cross-linked after allergen stimulation and induced release of significant levels of β-hexosaminidase (35%-80%) from a humanized rat basophilic cell line. Conclusions: Human IgE monoclonal antibodies are unique antibody molecules with potential applications in allergy diagnosis, allergen standardization, and identification of allergenic epitopes for the development of allergy therapeutics. The IgE antibody probes will enable the unequivocal localization and validation of allergenic epitopes.

Precision engineering for localization, validation and modification of allergenic epitopes

IgE binding epitope mapping with TL1A tagged peptides

Molecular allergy diagnosis: status anno 2015

Design of an Ara h 2 hypoallergen from conformational epitopes

Unique allergen-specific human IgE monoclonal antibodies derived from patients with allergic disease

Antibodies Specific for a Segment of Human Membrane IgE Deplete IgE-producing B Cells in Humanized Mice.

Reduction of Serum IgE by Depletion of the IgE B Cell Lineage - a Novel Approach for the Treatment of Allergic Diseases (140.7)

A Cell-Free Protein Synthesis Platform to Produce a Clinically Relevant Allergen Panel

Gene Editing in Allergic Diseases: Identification of Novel Pathways and Impact of Deleting Allergen Genes

The Potential of Human Monoclonal IgE Antibodies to Establish Biological Potency and Stability of Allergen Extracts

Precision medicine in food allergy

Molecular Allergy Diagnostics: Analytical Features That Support Clinical Decisions

Epitope-Directed Antibody Elicitation by Genetically Encoded Chemical Cross-Linking Reactivity in the Antigen

Epitope-directed Antibody Selection by Site-Specific Photocrosslinking

Epigenetic Mechanisms in Allergy Development and Prevention

Allergen Immunotherapy (AIT): a prototype of Precision Medicine

Allergen Microarrays and New Physical Approaches to More Sensitive and Specific Detection of Allergen-Specific Antibodies

Determination of IgE functional epitope and molecular design of IgE antagonist:research advance

Localization and Antigenicity Reduction of Immunodominant Conformational IgE Epitopes on Αs1-Casein

Biomarkers in Food Allergy

Mammalian cell display with automated oligo design and library assembly allows for rapid residue level conformational epitope mapping